X

Health Care

Earnings Summary: Revvity (RVTY) reports higher Q2 2025 revenues

Revvity, Inc. (NYSE: RVTY), a provider of health science solutions and technologies, on Monday reported an increase in revenues for…

Earnings: A snapshot of Thermo Fisher Scientific’s (TMO) Q2 2025 report

Thermo Fisher Scientific Inc. (NYSE: TMO), a global leader in life sciences, on Wednesday announced financial results for the second…

Abbott Laboratories (ABT) Q2 2025 sales and earnings beat estimates

Abbott Laboratories (NYSE: ABT) on Thursday announced financial results for the second quarter of fiscal 2025, reporting an increase in…

Key highlights from Johnson & Johnson’s (JNJ) Q2 2025 earnings results

Johnson & Johnson (NYSE: JNJ) reported its second quarter 2025 earnings results today. Reported sales increased 5.8% year-over-year to $23.7…

Johnson & Johnson to report Q2 earnings on July 16. Here’s what to expect

Johnson & Johnson's (NYSE: JNJ) business strategy for fiscal 2025 is focused on reducing the impact of patent expirations on…

Molina Healthcare reports preliminary Q2 2025 financial results

Molina Healthcare Inc. (NYSE: MOH), a managed care company focused on providing healthcare services to low-income individuals, on Monday reported preliminary…

Plus Therapeutics CEO: Lead candidate REYOBIQ demonstrates strong safety and efficacy in early trials

Plus Therapeutics (NASDAQ: PSTV) is a pharmaceutical company engaged in the development of targeted radiotherapeutics for difficult-to-treat cancers. Currently, it…

Earnings Summary: CooperCompanies (COO) reports higher Q2 revenue and profit

Medical device maker CooperCompanies (NYSE: COO) has reported an increase in adjusted earnings for the second quarter of 2025, aided…

Hinge Health is all set to go public. What investors need to know

The IPO market has witnessed steady activity so far this year, despite fluctuations in momentum across months. The technology industry…

MDT Earnings: A snapshot of Medtronic’s Q4 2025 report

Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported higher revenues for the fourth quarter of 2025, which translated…

Earnings Summary: Henry Schein (HSIC) reports higher Q1 2025 profit

Henry Schein, Inc. (Nasdaq: HSIC), a provider of healthcare solutions to office-based dental and medical practitioners, Monday reported an increase in…

Earnings Summary: Cigna Group (CI) reports 14% growth in Q1 2025 revenue

The Cigna Group (NYSE: CI), a healthcare company focused on medical insurance and related services, reported results for the first quarter…

BIIB Earnings: Biogen Q1 2025 adj. profit drops despite higher revenues

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Thursday reported a year-over-year decrease in adjusted profit for the first quarter of 2025,…

Infographic: How Eli Lilly (LLY) performed in Q1 2025

Eli Lilly and Company (NYSE: LLY) reported its first quarter 2025 earnings results today. Worldwide revenue was $12.73 billion, up…

Earnings: CVS Health Q1 2025 revenue and profit beat estimates

Healthcare conglomerate CVS Health Corporation (NYSE: CVS) reported higher revenues and adjusted profit for the first quarter of 2025. The…

Key highlights from Pfizer’s (PFE) Q1 2025 earnings results

Pfizer Inc. (NYSE: PFE) reported its first quarter 2025 earnings results today. Revenues decreased 8% year-over-year to $13.7 billion. GAAP…

Earnings Summary: Revvity (RVTY) reports higher revenue and earnings for Q1 2025

Revvity, Inc. (NYSE: RVTY), a provider of health science solutions and technologies, on Monday reported an increase in revenue and…

Earnings Summary: HCA Healthcare reports higher Q1 2025 revenue and profit

HCA Healthcare, Inc. (NYSE: HCA) on Friday reported an increase in revenues and net income for the first quarter of…

AbbVie Q1 2025 adjusted earnings increase on 8% revenue growth; beat estimates

Biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) announced first-quarter 2025 financial results, reporting an increase in revenue and adjusted earnings. The…

Bristol-Myers Squibb swings to profit in Q1 2025; revenue drops

Bristol Myers Squibb (NYSE: BMY) reported net profit for the first quarter of 2025, compared to a loss last year.…

MRK Earnings: Merck & Co. Q1 adj. profit rises, beats estimates

Merck & Co. Inc. (NYSE: MRK) Thursday reported an increase in adjusted earnings for the first quarter of 2025, while…